Zymeworks BC Profit Margin

The latest profit margin for ZYME is -4327006.32% as of June 2026. That compares with -24330.23% in the prior-year period — down 17684.5% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Zymeworks BC's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZYME's profit margin moved from -24330.23% to -4327006.32% — a 17684.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zymeworks BC's valuation or profitability profile.

Against Healthcare companies, ZYME currently prints -4327006.32% for profit margin, while the sector average sits near 9.48%. That is roughly 45638993.2% below the sector mean. Large gaps often invite a closer look at Zymeworks BC's growth, margins, and balance sheet.

Profit Margin shows how effectively Zymeworks BC converts resources into returns. At -4327006.32%, ZYME may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -24330.23% in the prior-year period — down 17684.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZYME's profit margin (-4327006.32%), review year-over-year change from -24330.23%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.